ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+39.12%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$208M
AUM Growth
+$208M
(+79%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
30.59%
Top 10 Holdings %
Top 10 Hldgs %
64.06%
Holding
34
New
14
Increased
9
Reduced
4
Closed
1
Top Buys
| 1 |
Insmed
INSM
|
$10.8M |
| 2 |
DERM
Dermira, Inc.
DERM
|
$8.63M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$6.87M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$5.83M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$4.82M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$7.27M |
| 2 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
$1.92M |
| 3 |
Veracyte
VCYT
|
$1.53M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$713K |
| 5 |
Outlook Therapeutics
OTLK
|
$15K |
Sector Composition
| 1 | Healthcare | 86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $28M | 13.31% | 2,944,201 -75,000 | -2% | -$713K |
|
|
KDMN
2
DELISTED
Kadmon Holdings, Inc.
KDMN
| $20.2M | 9.58% | 7,635,000 +97,000 | +1% | +$256K |
|
3
Assembly Biosciences
ASMB
$190M
| $15M | 7.12% | 760,500 +42,000 | +6% | +$827K |
|
|
CASM
4
DELISTED
CAS Medical Systems, Inc.
CASM
| $12.8M | 6.08% | 5,263,508 | – | – |
|
|
5
Insmed
INSM
$28.8B
| $10.8M | 5.11% | +370,000 | New | +$10.8M |
|
|
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.6M | 5.04% | 206,000 +18,500 | +10% | +$952K |
|
|
IMMU
7
DELISTED
Immunomedics Inc
IMMU
| $9.61M | 4.57% | 500,000 +100,000 | +25% | +$1.92M |
|
|
8
Veracyte
VCYT
$2.39B
| $9.55M | 4.54% | 381,500 -61,000 | -14% | -$1.53M |
|
|
DERM
9
DELISTED
Dermira, Inc.
DERM
| $8.63M | 4.1% | +636,500 | New | +$8.63M |
|
10
argenx
ARGX
$43.6B
| $7.93M | 3.77% | 63,500 +10,500 | +20% | +$1.31M |
|
|
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
| $6.87M | 3.27% | +517,500 | New | +$6.87M |
|
|
VRAY
12
DELISTED
ViewRay, Inc.
VRAY
| $6.02M | 2.86% | 815,000 +503,500 | +162% | +$3.72M |
|
13
KalVista Pharmaceuticals
KALV
$678M
| $5.88M | 2.8% | 205,500 +32,500 | +19% | +$930K |
|
|
14
Enanta Pharmaceuticals
ENTA
$180M
| $5.83M | 2.77% | +61,000 | New | +$5.83M |
|
15
Xenon Pharmaceuticals
XENE
$2.98B
| $5.61M | 2.67% | 552,500 +15,000 | +3% | +$152K |
|
16
IRIDEX
IRIX
$22.8M
| $5.36M | 2.55% | 1,174,500 | – | – |
|
|
DRNA
17
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.82M | 2.29% | +328,825 | New | +$4.82M |
|
18
Adverum Biotechnologies
ADVM
$64.6M
| $4.82M | 2.29% | +919,000 | New | +$4.82M |
|
19
Arvinas
ARVN
$568M
| $4.64M | 2.2% | +314,000 | New | +$4.64M |
|
20
Protagonist Therapeutics
PTGX
$3.67B
| $4.24M | 2.02% | +337,500 | New | +$4.24M |
|
21
Alector
ALEC
$238M
| $3.74M | 1.78% | +200,000 | New | +$3.74M |
|
|
ACER
22
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $3.57M | 1.7% | 147,000 +4,000 | +3% | +$97.2K |
|
23
Arrowhead Research
ARWR
$3.05B
| $3.07M | 1.46% | +167,500 | New | +$3.07M |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.01M | 1.43% | +41,000 | New | +$3.01M |
|
|
QTNT
25
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $2.52M | 1.2% | +280,000 | New | +$2.52M |
|